Table 3 Adverse events during the study
N (%) | |
|---|---|
Mild adverse events | 6 (3.7) |
Anxiety and hypercholesterolemia | 1 (0.6) |
Abdominal pain, dyspepsia, and asthenia | 1 (0.6) |
Irascibility and insomnia | 1 (0.6) |
Pyrosis | 1 (0.6) |
Sexual dysfunction | 1 (0.6) |
Diarrhea | 1 (0.6) |
Grade 3–4 adverse events | 0 (0) |